These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11978526)

  • 1. Biological therapy of colorectal cancer.
    de Kleijn EM; Punt CJ
    Eur J Cancer; 2002 May; 38(7):1016-22. PubMed ID: 11978526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for colorectal cancer.
    Foon KA
    Curr Oncol Rep; 2001 Mar; 3(2):116-26. PubMed ID: 11177743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer as a model for immunotherapy.
    Foon KA; Yannelli J; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1999 Feb; 5(2):225-36. PubMed ID: 10037169
    [No Abstract]   [Full Text] [Related]  

  • 8. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.
    Maxwell-Armstrong C
    Ann R Coll Surg Engl; 2002 Sep; 84(5):314-8. PubMed ID: 12398121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.
    Birebent B; Somasundaram R; Purev E; Li W; Mitchell E; Hoey D; Bloom E; Mastrangelo M; Maguire H; Harris DT; Staib L; Braumuller H; Leeser C; Kuttner N; Beger HG; Herlyn D
    Crit Rev Oncol Hematol; 2001; 39(1-2):107-13. PubMed ID: 11418307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for colorectal cancer.
    Zeh HJ; Stavely-O'Carroll K; Choti MA
    Trends Mol Med; 2001 Jul; 7(7):307-13. PubMed ID: 11425639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant immunotherapy for melanoma and colorectal cancers.
    Safa MM; Foon KA
    Semin Oncol; 2001 Feb; 28(1):68-92. PubMed ID: 11254868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunology of colorectal cancer.
    Zbar AP
    Surg Oncol; 2004; 13(2-3):45-53. PubMed ID: 15572086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
    Zbar AP; Thomas H; Wilkinson RW; Wadhwa M; Syrigos KN; Ross EL; Dilger P; Allen-Mersh TG; Kmiot WA; Epenetos AA; Snary D; Bodmer WF
    Int J Colorectal Dis; 2005 Sep; 20(5):403-14. PubMed ID: 15864608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
    Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
    Staib L; Birebent B; Somasundaram R; Purev E; Braumüller H; Leeser C; Küttner N; Li W; Zhu D; Diao J; Wunner W; Speicher D; Beger HG; Song H; Herlyn D
    Int J Cancer; 2001 Apr; 92(1):79-87. PubMed ID: 11279610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.
    Samonigg H; Wilders-Truschnig M; Loibner H; Plot R; Rot A; Kuss I; Werner G; Stöger H; Wrann M; Herlyn D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):271-7. PubMed ID: 1451329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.